Sana Kliniken AG

Clinical Evaluation of the Osteoporotic Fracture Treatment Score (OF-Score): Results of the Evaluation of the Osteoporotic Fracture Classification, Treatment Score and Therapy Recommendations (EOFTT) Study (2023) Ullrich BW, Schnake KJ, Schenk P, Katscher S, Bäumlein M, Zimmermann V, Schwarz F, et al. Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2023. (2023) Thill M, Kolberg-Liedtke C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, et al. Journal article, Review article Gestational and Non-gestational Trophoblastic Neoplasia. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 032/049, April 2022). (2023) Tempfer C, Horn LC, Ackermann S, Dittrich R, Einenkel J, Günthert A, Haase H, et al. Journal article Preoperative hormone stimulation; does it increase hypospadias postoperative complications? (2023) Fawzy M, Marcou M, Sennert M, Wirmer J, Wullich B, T Hadidi A Journal article Clinical Results and Quality of Life After Transcortical Versus Transcallosal Resection of Adult Lateral and Third Ventricle Lesions: Long-Term Outcome (2023) AlSharif M, Stroop R, Scholz M, Buchfelder M, Wiendieck K, Shiban E, Sommer B Journal article Survey on brachytherapy training among radiation oncology residents in the German-speaking regions of Europe (2023) Knoth J, Konrad S, Lössl K, Motisi L, Mäurer M, Linde P, Lindel K, et al. Journal article Georg Schmorl prize of the German spine society (DWG) 2022: current treatment for inpatients with osteoporotic thoracolumbar fractures—results of the EOFTT study (2023) Ullrich BW, Schenk P, Scheyerer MJ, Bäumlein M, Katscher S, Schnake KJ, Zimmermann V, et al. Journal article Myasthenia gravis - in pregnancy, during labor and in puerperium Myasthenia gravis - in der Schwangerschaft, unter der Geburt und im Wochenbett (2023) Kühnert M, Kehl S, Kuschel B, Schäfer-Graf U, Schmidt M Journal article Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response (2022) Loibl S, Schneeweiss A, Huober J, Braun M, Rey J, Blohmer JU, Furlanetto J, et al. Journal article Corrigendum to “A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study”: [Annals of Oncology (2019), volume 30:1279-1288, (Annals of Oncology (2019) 30(1279-1288) (S0923753419312785)) (2022) Loibl S, Untch M, Burchardi N, Huober J, Sinn BV, Blohmer JU, Grischke EM, et al. Journal article, Erratum